Ep Wealth Advisors, LLC Astrazeneca PLC Transaction History

Ep Wealth Advisors, LLC

$11.3 Billion
Q3 2024

A detailed history of Ep Wealth Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Ep Wealth Advisors, LLC holds 20,436 shares of AZN stock, worth $1.41 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

20,436

Previous 17,052 19.85%

Holding current value

$1.41 Million

Previous $1.33 Million 19.79%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $259,451 - $296,506	3,384 Added 19.85%	20,436 $1.59 Million
Q2 2024 Aug 19, 2024	BUY	$66.81 - $80.83 $48,904 - $59,167	732 Added 4.49%	17,052 $1.33 Million
Q1 2024 May 14, 2024	SELL	$61.03 - $69.57 $70,855 - $80,770	-1,161 Reduced 6.64%	16,320 $1.11 Million
Q4 2023 Feb 28, 2024	BUY	$61.89 - $69.28 $113,691 - $127,267	1,837 Added 11.74%	17,481 $1.18 Million
Q3 2023 Nov 22, 2023	BUY	$64.85 - $71.7 $48,637 - $53,775	750 Added 5.04%	15,644 $1.06 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $232,171 - $251,765	-3,321 Reduced 18.23%	14,894 $1.07 Million
Q1 2023 Jun 05, 2023	BUY	$63.15 - $71.6 $1.15 Million - $1.3 Million	18,215 New	18,215 $1.26 Million
Q4 2022 Jun 12, 2023	SELL	$54.21 - $70.44 $50,090 - $65,086	-924 Reduced 5.07%	17,291 $1.17 Million
Q2 2022 Aug 11, 2022	BUY	$59.26 - $71.14 $206,402 - $247,780	3,483 Added 42.31%	11,716 $774,000
Q1 2022 May 20, 2022	SELL	$55.72 - $67.12 $14,208 - $17,115	-255 Reduced 3.0%	8,233 $546,000
Q4 2021 Feb 17, 2022	SELL	$54.02 - $63.83 $27,604 - $32,617	-511 Reduced 5.68%	8,488 $494,000
Q3 2021 Nov 23, 2021	SELL	$55.56 - $60.79 $1.72 Million - $1.88 Million	-30,922 Reduced 77.46%	8,999 $540,000
Q3 2021 Nov 16, 2021	BUY	$55.56 - $60.79 $1.83 Million - $2 Million	32,900 Added 468.59%	39,921 $540,000
Q2 2021 Aug 24, 2021	BUY	$48.42 - $60.18 $37,380 - $46,458	772 Added 12.35%	7,021 $421,000
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $801 - $925	17 Added 0.27%	6,249 $311,000
Q4 2020 Feb 18, 2021	BUY	$48.52 - $58.02 $302,376 - $361,580	6,232 New	6,232 $312,000
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $199,380 - $255,864	-4,626 Closed	0 $0
Q1 2020 May 18, 2020	SELL	$37.79 - $51.33 $30,156 - $40,961	-798 Reduced 14.71%	4,626 $207,000
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $52,183 - $62,015	-1,229 Reduced 18.47%	5,424 $270,000
Q3 2019 Nov 18, 2019	BUY	$40.12 - $45.47 $266,918 - $302,511	6,653 New	6,653 $297,000

Others Institutions Holding AZN

# of Institutions

1,340

Shares Held

476M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $214B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ep Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ep Wealth Advisors, LLC with notifications on news.

Account

Ep Wealth Advisors, LLC Astrazeneca PLC Transaction History